Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 10:22 PM
Study NCT ID:
NCT05573958
Status:
UNKNOWN
Last Update Posted:
2022-10-10
First Post:
2022-09-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
Sponsor:
Sarmad Zahoor
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-09
First Submit QC Date:
None
Study First Post Date:
2022-10-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-05
Last Update Post Date:
2022-10-10
Last Update Post Date Type:
ACTUAL